Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Tenax Therapeutics, Inc. Common Stock, par value $0.0001 per share (TENX).
- Disclosed ownership: 6.9%.
- Date of event: 30 Sep 2025.
INTEGRATED CORE STRATEGIES (US) LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Tenax Therapeutics, Inc. Common Stock, par value $0.0001 per share (TENX)
- Filing Manager
- INTEGRATED CORE STRATEGIES (US) LLC
- Reporting Manager
- Integrated Core Strategies (US) LLC
- Symbol
- TENX
- Shares outstanding
- 4,546,551 shares
- Disclosed Ownership
- 313,712 shares
- Ownership
- 6.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Nov 2025, 16:24:57 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 6.9% ownership in Tenax Therapeutics, Inc. Common Stock, par value $0.0001 per share (TENX) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 30 Jun 2025.
- Current filing was accepted on 05 Nov 2025, 16:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 6.9% | 313,712 | 0 | 313,712 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 6.9% | 313,712 | 0 | 313,712 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 6.9% | 313,712 | 0 | 313,712 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 6.9% | 313,712 | 0 | 313,712 | /s/ Israel A. Englander | Israel A. Englander |